Co infección por Virus de Inmunodeficiencia Humana y Hepatitis B en una Clínica de Alta Complejidad de Barranquilla 2010 2017
| dc.contributor.advisor | Arquez Mendoza, Moisés Alberto | spa |
| dc.contributor.advisor | González Torres, Henry | spa |
| dc.contributor.author | Britto Rivera, Mitzy | |
| dc.contributor.author | Mórelo Espitia, Gleymer | |
| dc.contributor.author | Romero Martínez, Vanessa | |
| dc.date.accessioned | 2020-01-15T17:00:33Z | |
| dc.date.available | 2020-01-15T17:00:33Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Introducción: La coinfección entre el Virus de Hepatitis B-VHB y el Virus de Inmunodeficiencia Humana-VIH es un evento que se puede presentar en pacientes con determinadas características según diversos estudios relacionados. Su incidencia es variada, pero no muy conocida en el país y en la costa caribe de Colombia. Objetivo: Dado lo anterior se determinó caracterizar y determinar la incidencia de coinfección entre VIH/VHB en la población adulta atendida en la Clínica de la Costa en la ciudad de Barranquilla en el periodo comprendido de 01 de Enero de 2.010 a 31 de Diciembre de 2017. | spa |
| dc.description.abstract | Introduction: Co-infection between Hepatitis B-HBV Virus and Human Immunodeficiency Virus-HIV is an event that can occur in patients with certain characteristics according to various related studies. Its incidence is varied, but not well known in the country and on the Caribbean coast of Colombia. Objective: Given the above, it was determined to characterize and determine the incidence of HIV / HBV co-infection in the adult population treated at the Costa Clinic in the city of Barranquilla in the period from January 1, 2010 to December 31, 2017. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/4515 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Infecciones por VIH | spa |
| dc.subject | Coinfección | spa |
| dc.subject | Hepatitis B | spa |
| dc.subject | Infecciones oportunistas relacionadas con el SIDA | spa |
| dc.subject | VIH infections | eng |
| dc.subject | Coinfection | eng |
| dc.subject | AIDS-Related Opportunistic Infections | eng |
| dc.title | Co infección por Virus de Inmunodeficiencia Humana y Hepatitis B en una Clínica de Alta Complejidad de Barranquilla 2010 2017 | spa |
| dc.type | Other | spa |
| dcterms.references | Salud. O-OM de la. Hepatitis B. Notas descriptivas. Cent prensa [Internet]. 2018; Available from: https://www.who.int/es/news-room/fact-sheets/detail/hepatitis-B | spa |
| dcterms.references | ONUSIDA. Últimas estadísticas sobre el estado de la epidemia de sida. Cent Prensa [Internet]. 2018; Available from: https://www.unaids.org/es/resources/fact-sheet | spa |
| dcterms.references | Mandell D y B. Enfermedades infecciosas. Principios y práctica. 8th ed. Elsevier. Elsevier; 2016. | spa |
| dcterms.references | Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M’boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, Njouom R F-SS. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS One. 2018;13(1):e0190592. | eng |
| dcterms.references | Mertens TE L-BD. HIV and AIDS: Where is the epidemic going? World Heal Organ. 2010;74(2):121–9. | eng |
| dcterms.references | Soza A. Coinfección de hepatitis B y C con VIH. Medwave. 2007;5:3324. | spa |
| dcterms.references | Salud. M de S-IN de. Hepatitis B, C y Coinfección/Superinfección hepatitis B-Delta. Protocolo de Vigilancia en Salud Pública. Bogotá; 2017. | spa |
| dcterms.references | Agyeman AA O-AR. Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis. AIDS Res Ther [Internet]. 2016;13:23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4869330&tool=pmcentrez&rendertype=abstract | eng |
| dcterms.references | CL T. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2010;49(5):17360–7. | eng |
| dcterms.references | Berger A, Preiser W DH. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. j Clin Vir [Internet]. 2011;20:23–30. Available from: http://www.sciencedirect.com/science/article/pii/S1386653200001517 | eng |
| dcterms.references | Bobek V, Kolostova K, Pinterova D, Kacprzak G, Adamiak J, Kolodziej J et al. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma. Anticancer Res. 2010;30(12):4799–804. | eng |
| dcterms.references | Oliveira SB de, Merchán-Hamann E AL. HIV/AIDS coinfection with the hepatitis B and C viruses in Brazil. Cad sau pub. 2014;30(2):433–8. | eng |
| dcterms.references | S C. Collection S. HHS Public Access. 2016;8(5):583–92. | eng |
| dcterms.references | M. L-B. Coinfección de hepatitis B e infección por VIH. Ac Med Col. 2008;50(3):50–3. | spa |
| dcterms.references | De La Hoz JM, Bolaño L, Cárdenas O, González R, Sabbag J, Palacio L et al. Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region. Col Med. 2014; | eng |
| dcterms.references | Puglia M, Stasi C VF. Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany. Bra J Inf Dis. 2016;20(4):330–4. | eng |
| dcterms.references | Mallet V, Hamed K SM. Prognosis of Patients with Chronic Hepatitis B in France (2008-2013): A Nationwide, Observational and Hospital-based Study. J Hepatol [Internet]. 2016; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0168827816306420 | eng |
| dcterms.references | Bautista-Amorocho H, Castellanos-Domínguez YZ, Rodríguez-Villamizar LA, Velandia-Cruz SA, Becerra-Peña JA F-GA. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: High prevalence of occult hepatitis B and F3 subgenotype dominance. PLoS One. 2014;9(12):1–14. | eng |
| dcterms.references | UNAIDS. Global-SIDA-update-2016. UNAIDS [Internet]. 2016; Available from: http://www.unaids.org/sites/default/files/media_asset/globalSIDA-update-2016_en.pdf. | eng |
| dcterms.references | Ruiz P, Téllez-Molina MJ, Vergas-García J, Altali-Alhames K F-CA. Coinfección por VIH/VHB: estrategias terapéuticas y control serológico. Rev Clin Esp. 2103; | spa |
| dcterms.references | L M. Interacciones entre el virus de la hepatitis y el VIH. Lancet Infect Dis. 2014;14(11):1025–7. | spa |
| dcterms.references | Polo P, Castañeda C, Sierra M AN. Occult Hepatitis B co-infection in health center patients with HIV in Vitalsalud IPS Barranquilla, Colombia. Programa Integr Atención del VIH Univ Cart Grup Investig en Econ la Salud. 2010; | eng |
| dcterms.references | Tobón-Pereira JC T-MA. Study of the patient with HIV infection. Med Lab. 2008;14(11):20. | eng |
| dcterms.references | Yeom JS, Jun G, Chang Y, Sohn MJ, Yoo S, Kim E et al. Evaluation of a new fourth generation enzyme-linked immunosorbent assay, the LG HIV Ag-Ab Plus, with a combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods. 206AD;137:292–7. | eng |
| dcterms.references | Yeom JS, Lee JB, Ryu SH, Kang HJ, Kim S, Kim YA et al. No TitleEvaluation of a new third-generation ELISA for the detection of HIV infection. Ann Clin Lab Sci. 2006;36:73–8. | eng |
| dcterms.references | L. G. Difficulties and strategies of HIV diagnosis. Lancet. 1996;348:176–9. | eng |
| dcterms.references | DeSimone JA PR. New methods for the detection of HIV. Clin Lab Med. 2002;22:573–92. | eng |
| dcterms.references | Kimmel AD, Losina E, Freedberg KA GS. Diagnostic tests in HIV management: a review of clinical and laboratory strategies to monitor HIV-infected individuals in developing countries. No Title. Bull World Heal Organ. 2006;84:581–8. | eng |
| dcterms.references | Schupbach J, Boni J, Flepp M, Tomasik Z JH, M. O. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. J Med Virol. 2001;65:225–32. | eng |
| dcterms.references | Montoro MA GJ. Problemas comunes en la práctica clínica. Jarpyo Editores, editor. Gastroenterologia y Hepatologia. 2012. | spa |
| dcterms.references | Piroth L, Sene D, Pol S, Goderel I, Lacombe K MB, Al. E. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS. 2007;21: 1323–31. | eng |
| dcterms.references | Manegold C, Hannoun C, Wywiol A, Dietrich M PS, Chiwakata CB et al. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2001; 32: 144– 8. | eng |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Ley 100. Bogotá; 1993. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Ley 715. Bogotá; 2001. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Ley 1098. Bogotá; 2006. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Ley 972. Bogotá; 2005. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Decreto 2323. Bogotá; 2006. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Decreto 3518. Bogotá; 2006. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Decreto 1543. Bogotá; 1997. | spa |
| dcterms.references | Ministerio de Salud y Protección Social de Colombia. Resolución 3442. Bogotá; 2006. | spa |
| dcterms.references | M. G-D. Rapid Initiation of Antiretroviral Therapy after HIV Diagnosis. AIDS Rev. 2019;21(2):55–64. | eng |
| dcterms.references | Frempong MT, Ntiamoah P, Annani-Akollor ME, Owiredu WKBA, Addai-Mensah O, Owiredu EW, Adu-Gyasi D, Agyapong EO SL. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo Region, Ghana. PLoS One. 2019;14(7):e0219922. | eng |
| dcterms.references | Hashiani AA, Sadeghi F, Ayubi E, Rezaeian S, Moradi Y, Mansori K, Gholamaliei B, Mohammadbeigi A KS. Prevalence of HIV, Hepatitis B and C Virus Co-infections among Iranian High-Risk Groups: A Systematic Review and Meta-Analysis. Malays J Med Sci. 2019;26(3):37–48. | eng |
| dcterms.references | McKee G, Butt ZA, Wong S, Salway T, Gilbert M, Wong J, Alvarez M, Chapinal N, Darvishian M, Tyndall MW, Krajden M JN. Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study. EClinicalMedicine. 2018;4(5):99–108. | eng |
| dcterms.references | Altawalah H, Essa S, Ezzikouri S A-NW. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study. Sci Rep. 2019;9(1):6292. | eng |
| dcterms.references | Scheibe A, Young K, Moses L, Basson RL, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Manamela J, Puren AJ, Rebe K HH. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduct J. 2019;16(1):28. | eng |
| dcterms.references | Omatola CA, Lawal C, Omosayin DO, Okolo MO, Adaji DM, Mofolorunsho CK BK. Seroprevalence of HBV, HCV, and HIV and Associated Risk Factors Among Apparently Healthy Pregnant Women in Anyigba, Nigeria. Viir immu. 2019;32(4):183–91. | eng |
| dcterms.references | Opaleye OO, Igboama MC, Ojo JA OG. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria. Immu Immu. 2016;37(1):29–42. | eng |
| dcterms.references | Ramos JM, Toro C, Reyes F, Amor A GF. Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia. J Clin Virol. 2011;51(1):83–5. | eng |
| dcterms.references | Hepatitis B. In: Pathologie Biologie. Elsevier Masson; 2011. p. 243–314. | eng |
| dcterms.references | Desikan P KZ. Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis. Indian J Med Microbiol. 2017;35:332–9. | eng |
| dcterms.references | SIVIGILA. S de VE. Boletín Epidemiológico Semana 52. Programa de VIH-Barranquilla. 2018. | spa |
| dcterms.references | Salud. IN de. Boletín Epidemiológico Semana 47 [Internet]. Bogotá; 2018. Available from: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2018 Boletín epidemiológico semana 47.pdf. | spa |
| dcterms.references | Mutagoma M, Balisanga H, Malamba SS, Sebuhoro D, Remera E, Riedel DJ, Kanters S NS. Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):18. | eng |
| oaire.version | info:eu-repo/semantics/submittedVersion | spa |
| sb.programa | Especialización en Medicina Interna | spa |
| sb.sede | Sede Barranquilla | spa |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 2.93 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: